Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Circassia raises funds to develop allergy products

April 19, 2011 Research and Development Circassia, UK biotech, biotech

UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …
News
Pfizer

Phase III boost for Pfizer’s oral arthritis drug

April 18, 2011 Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Pfizer’s rheumatoid arthritis treatment tofacitinib has induced clinical remission of the disease according to one-year data from a phase III …
News
Genzyme's headquarters

Genzyme MS drug shines in head-to-head trial with Rebif

April 18, 2011 Research and Development, Sales and Marketing Genzyme, Lemtrada, Sanofi-Aventis, relapsing multiple sclerosis

Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial. Five years’ worth of mid-stage data …
News

GlaxoSmithKline to drop Alli and other OTC products

April 15, 2011 Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb

GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …
News
roche

Roche growth stalls after Avastin setback

April 14, 2011 Research and Development, Sales and Marketing Roche

Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …
News

Watermeadow continues to grow

April 14, 2011 Research and Development Watermeadow, awards, employees, growth

Watermeadow Medical is delighted to welcome seven new staff to its UK offices. The appointments have been made as demand …
Appointment
Lonza, Slough

Lonza expands UK facility, bio business reports growth

April 13, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, Lonza, Slough, manufacturing

Swiss contract manufacturer and fine chemicals company Lonza has said it plans to expand its biopharmaceutical production unit in Slough, …
News

FDA committee votes in Afinitor’s favour

April 13, 2011 Research and Development, Sales and Marketing

The FDA advisory committee has unanimously backed Novartis’ Afinitor for neuroendocrine tumours of pancreatic origin.  The recommendation comes from the …
News

Free Pharmacovigilance Training Webinar

April 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

 Wainwright Associates are offering you the opportunity to attend a FREE thirty minute webinar on “The roles and responsibilities of …
News
Press release

Working Life: Merck Serono’s Wolfgang Wein

April 6, 2011 Research and Development, Sales and Marketing Working Life

Head of oncology at Merck Serono Wolfgang Wein explains how his field is changing, the best thing about his role …
News

Evil big pharma: myth or material?

April 6, 2011 Research and Development, Sales and Marketing Les Rose, industry reputation

In the US the False Claims Act regulates those who attempt to defraud the government. In the last 20 years, …
Feature

Merck acquires eyecare specialist Inspire

April 6, 2011 Research and Development, Sales and Marketing Inspire, Merck, eye care

Merck & Co is to buy ophthalmic specialist Inspire Pharmaceuticals in a $430 million deal which sees it move further …
News
Boehringer Andreas Barner

Boehringer bets on Pradaxa to fill portfolio gaps

April 6, 2011 Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa

Boehringer Ingelheim has identified Pradaxa as one of the cornerstones of its “new growth phase” as the manufacturer seeks to …
News
pfizer_belgium_kris_westelinck

Kris Westelinck appointed president of Pfizer Belgium

April 5, 2011 Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, researcha and development, sales and marketing

Pfizer Belgium has promoted Kris Westelinck to the role of president. Kris was previously managing director and head of Pfizer’s …
Appointment

ABPI appoints new head

April 5, 2011 Manufacturing and Production, Research and Development, Sales and Marketing ABPI, appointment

The ABPI has appointed former Prudential communications director Stephen Whitehead as its new head. He joins the UK pharma industry …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026